• Immunosuppression minimization: what is safe?

  • Immunosuppression minimization: what is safe?

  • Immunosuppression minimization: what is safe?

#Immunosuppression #Latin America

Live Session:

Wednesday, July 7, 2021 - 6:00 PM (Local time in Buenos Aires)
Local time (Corresponding local time at your current location)

Join us:

Register

Description:

This masterclass aims to review and discuss the current and future proposals to attain personalized immunosuppression and drug minimization in kidney transplanted patients. It will also discuss the local resources to accomplish this goal and these protocols’ results.

Learning Objectives:

  • To review current and future strategies to perform a personalized and minimized immunosuppression

  • To discuss which are the opportunities and results in the region

Faculty:

Personalized immunosuppression and minimization: where are we now and what is on the horizon

Ruth Sapir-Pichhadze

Assistant Professor Department of Medicine
Division of Experimental Medicine, McGill University
Montreal, Canada

Dr. Sapir-Pichhadze's research focuses on the application of personalized medicine strategies for the prevention of immune-mediated injuries. Specifically, she is interested in identifying genetic determinants of donor and recipient compatibility in an effort to optimize organ allocation schemes, inform personalized surveillance schedules, and establish individually tailored therapeutic regimens in kidney transplant candidates and recipients.

Are we doing this safely in the region?

Elias David-Neto

Professor of Medicine
Director, Renal Transplant Service
Hospital das Clinicas
University of São Paulo School of Medicine
São Paulo, Brazil

Schedule (90 min):

  • 05 min

    Welcome and introduction by the Chair

  • 25 min

    Presentation: Personalized immunosuppression and minimization: where are we now and what is on the horizon, Ruth Sapir-Pichhadze, Canada

  • 05 min

    Live Q&A with Ruth Sapir-Pichhadze, Canada

  • 25 min

    Presentation: Are we doing this safely in the region? Elias David-Neto, Brazil

  • 05 min

    Live Q&A with Elias David-Neto, Brazil

  • 20 min

    Interactive panel discussion with audience participation led by the Chairs

  • 05 min

    Masterclass closing remarks

Join Our Mailing List

Ask a Question

Masterclass Prospectus Request